Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (31)
NITAG documentation (1591)
Reports (55)
SAGE documentation (222)
Scientific publications (112)
Systematic reviews (SYSVAC) (2853)
Regions
Africa (274)
Americas (766)
Eastern Mediterranean (50)
Europe (705)
South-East Asia (81)
Western Pacific (199)
Diseases
Chikungunya (9)
Cholera (34)
COVID-19 (1513)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4864 results found
2024
∙
NACI
Addendum to the NACI statement on seasonal influenza vaccine for 2024-2025: Transition from quadrivalent to trivalent influenza vaccines
2024
∙
NACI
NACI Statement on seasonal influenza vaccine for 2024–2025
2024
∙
NACI
NACI Updated recommendations on human papillomavirus vaccines
2024
∙
SAGE
Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization on Ebola vaccination, May 2024
2024
∙
NIAC
recommendations for the passive immunisation of infants against Respiratory Synctytal Virus (RSV) during the 2024/2025 season
2024
∙
NIAC
Updated 2024 recommendations for COVID 19 vaccination
2024
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against seasonal influenza in Belgium - Winter season 2024-2025
2024
∙
STIKO
Modelling methods for predicting epidemiological and health economic effects of vaccinations. Guidance for analyses to be presented to the German Standing Committee on Vaccination (STIKO)
2024
∙
JCVI
JCVI Horizon Scanning sub-committee - Minute of the meeting held on 05 January 2024
2024
∙
ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2024
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register